BMO Capital Sticks to Their Buy Rating for UnitedHealth


In a report released today, Matthew Borsch from BMO Capital maintained a Buy rating on UnitedHealth (NYSE: UNH), with a price target of $300. The company’s shares closed yesterday at $252.81, close to its 52-week high of $256.73.

Borsch has an average return of 24.9% when recommending UnitedHealth.

According to TipRanks.com, Borsch is ranked #2420 out of 4830 analysts.

UnitedHealth has an analyst consensus of Strong Buy, with a price target consensus of $280.57.

See today’s analyst top recommended stocks >>

The company has a one-year high of $256.73 and a one-year low of $183.39. Currently, UnitedHealth has an average volume of 3.11M.

Based on the recent corporate insider activity of 174 insiders, corporate insider sentiment is negative on the stock. Most recently, in March 2018, Richard Burke, a Director at UNH bought 5,000 shares for a total of $181,250.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts